The Texas Heart Institute
E

Anticoagulation Management in Temporary Mechanical Circulatory Support Devices

By The Texas Heart Institute FEATURING Ellen Yin
By The Texas Heart Institute FEATURING Ellen Yin
5 views
January 26, 2024
0 Comments
Login to view comments. Click here to Login

Featured Video

18:06
Lilly Obesity

Getting Patients Started with an Obesity Treatment Option for Adults

Feat. E. Lazarus

Related Content

AUTOPLAY
11:37
ACC 2022 Conference Coverage

ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…

Feat. P. Heidenreich
11:25
ACC 2023 Conference Coverage

ACC 2023: SGLT2i Use - Dos and Don'ts

Feat. A. Armbruster
10:38
Getinge

HFSA 2023 - Counterpulsation Applications in Heart Failure: Restrict…

Feat. R. Lee
13:22
Getinge

HFSA 2023 - Intra-Aortic Balloon Pump – Bridge to Heart Transplant.

Feat. C. Gidea
14:49
Getinge

HFSA 2023 - Navigating MCS Selection Amidst the RCT Evidence Gap.

Feat. D. Baran
27:14
MUSC Cardiology

Which Diuretic(s) Are Best in HF? Update Based on Recent Clinical Tr…

Feat. R. Mentz
13:17
Getinge

HFSA 2023 - Physiological and Clinical Effects of Counterpulsation i…

Feat. I. Isseh
13:07
Michelle Kittleson

2021 ADA Highlights: Heart Failure With Reduced Ejection Fraction - …

61:00
Getinge

HFSA 2023 - Reviving Hearts, Renewing Lives the Evolution of Counter…

Feat. I. Isseh, C. Gidea, R. Lee, D. Baran
09:52
AHA 2022 Conference Coverage

AHA 2022: Torsemide Comparison With Furosemide for Management of Hea…

Feat. R. Mentz
17:25
Houston Shock Symposium

IABP in Shock: Do Kinetics Differ Based on Cannulation Strategy?

Feat. A. Civitello
09:49
David Baran

Intra-Aortic Balloon Pump: New Insights

35:16
Scripps Health

HFpEF or Amyloidosis? The Right Therapies for Right Patients

Feat. M. Kittleson
12:30
Houston Methodist Hospital

Amyloidosis Types and Pathophysiology

Feat. B. Trachtenberg
29:08
Scripps Health

Case Presentation: Complex PCI with IABP

Feat. R. Khedraki, T. Heywood, R. Mohan, A. Srivastava
30:04
Scripps Health

Menopause, Hormone Therapy, and the Heart: What the Evidence Shows

Feat. C. Shufelt
17:29
UCLA Health

Cardiac Amyloidosis: A New Era of Diagnostics and Therapeutics

Feat. D. Vucicevic
14:19
UChicago Medicine

S-QUAD Therapy and Beyond: HFpEF in 2024

Feat. M. Belkin
17:36
Mount Sinai Advanced Innovations in Heart Failure

Contemporary Management of Cardiogenic Shock: Updates in 2022

Feat. D. Baran
19:30
ACC 2022 Conference Coverage

Hot Topics in Heart Failure ACC.22

Feat. N. Ibrahim